服用伐尼克兰戒烟:肺血栓栓塞伴梗死的罕见原因
伐尼克兰是α4β2烟碱型乙酰胆碱受体部分激动剂和α7烟碱型乙酰胆碱受体完全激动剂,自2006年起用于戒烟,已知与心肌梗死等心血管不良事件相关,机制可能涉及α7受体激活、副交感输出、儿茶酚胺释放及促血栓作用。本文报告一例无心血管基础病的患者,在服用伐尼克兰期间发生肺血栓栓塞伴肺梗死,表现为右侧胁腹痛,Wells评分0分(肺血栓栓塞低概率),不良反应概率量表总分6分,提示伐尼克兰与肺血栓栓塞可能相关。该病例提示在服用伐尼克兰戒烟的患者中,即使肺血栓栓塞预测概率低,也应考虑该罕见不良反应的可能。
要点
- 服用伐尼克兰戒烟的患者出现右侧胁腹痛,需警惕肺血栓栓塞伴肺梗死,即使Wells评分为0分。
- 该患者无心血管基础病,Wells评分0分(低概率),仍发生肺血栓栓塞伴梗死。
- 不良反应概率量表总分6分,提示伐尼克兰与肺血栓栓塞可能相关。
- 伐尼克兰已知与心肌梗死等心血管不良事件相关,机制可能涉及α7烟碱型乙酰胆碱受体激活、副交感输出、儿茶酚胺释放及促血栓作用。
适用人群与场景
- 服用伐尼克兰戒烟、无心血管基础病的患者。
诊断标准与关键阈值
- Wells评分0分,提示肺血栓栓塞低概率。
- 不良反应概率量表总分6分,提示伐尼克兰与肺血栓栓塞可能相关。
红旗征与不能漏的情况
- 服用伐尼克兰期间出现右侧胁腹痛,需警惕肺血栓栓塞伴肺梗死。
研究设计与关键结果
- 病例报告:一例无心血管基础病患者在服用伐尼克兰戒烟期间发生肺血栓栓塞伴肺梗死,表现为右侧胁腹痛,Wells评分0分,不良反应概率量表总分6分,提示伐尼克兰与肺血栓栓塞可能相关。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,服用伐尼克兰戒烟的患者出现右侧胁腹痛时,即使Wells评分为0分,也应考虑肺血栓栓塞伴肺梗死的可能。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Varenicline (Champix®, Chantix®) is a partial agonist of the α4β2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the α7 nAChR. It has been used for smoking cessation since 2006. Varenicline has been associated with adverse cardiovascular (CV) events, including myocardial infarction, which may be caused by activation of the α7 nAChR receptor that in turn stimulates parasympathetic output from the brainstem to the heart, release of catecholamines, and has a prothrombotic effect. However, among the adverse CV events, the issue related to the varenicline-induced pulmonary thromboembolism (PTE) has not being addressed. We report a case of PTE with pulmonary infarction presenting as right flank pain that resulted from the use of varenicline (the total score of adverse drug reaction probability scale, 6; probable association between varenicline and pulmonary PTE) in a patient without underlying CV disease and in whom low probability of PTE (Wells score was zero) was identified.
参考来源
- Lee SH, Yun SJ, Ryu S, et al. Taking varenicline for smoking cessation: A rare cause of pulmonary thromboembolism with infarction. Am J Emerg Med. 2017. PMID: 28268112. doi:10.1016/j.ajem.2017.02.044
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。